Concepedia

Richard B. Womer

RB

Statistics

Publications

89

Citations

8.9K

H-Index

47

Active since

1983

Affiliations

Children's Hospital of Philadelphia(Current)

University of Pennsylvania

University of Southern California

Children's Oncology Group

Stanford University

Richard B. Womer is an author at Children's Hospital of Philadelphia specializing in medicine, oncology, and pediatric oncology.

ORCID

Publications per year

1983–2023

89

Publications

89

Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

Richard B. Womer, Daniel C. West, Mark Krailo et al. · Journal of Clinical Oncology · 2012 · 756 citations · Full text

, , +14

Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2008 · 748 citations · Full text

, , +14

Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

Paul A. Meyers, Cindy L. Schwartz, Mark Krailo et al. · Journal of Clinical Oncology · 2005 · 719 citations · Full text

, , +15

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

Akira Kawai, John H. Healey, I Fligman et al. · Journal of Clinical Oncology · 1998 · 525 citations

, , +17

Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose

Yuelin Li, Richard B. Womer, Jeffrey H. Silber · European Journal of Cancer · 2003 · 356 citations

, , +14

1–5 of 89